Trial Profile
A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Feb 2021
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Dyspnoea
- Focus Therapeutic Use
- 27 Jan 2021 Status changed from active, no longer recruiting to completed.
- 24 Jul 2020 Planned End Date changed from 1 Jan 2021 to 31 Dec 2022.
- 24 Jul 2020 Planned primary completion date changed from 1 Jan 2020 to 31 Dec 2021.